{"DataElement":{"publicId":"10560066","version":"1","preferredName":"Tumor Histology Type","preferredDefinition":"Response indicating the tumor histology type.","longName":"TUMOR_HST_TYP","context":"NRG","contextVersion":"1","DataElementConcept":{"publicId":"2528815","version":"1","preferredName":"Histology Grade","preferredDefinition":"The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._Describes how closely a cancer resembles normal tissue of its same type, and the cancer's probable rate of growth","longName":"2404668v1.0:2427327v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2404668","version":"1","preferredName":"Histology","preferredDefinition":"The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.","longName":"C16681","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histology","conceptCode":"C16681","definition":"The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"005AD6E5-068E-6A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-09","endDate":null,"createdBy":"DWARZEL","dateCreated":"2005-09-09","modifiedBy":"ONEDATA","dateModified":"2005-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2427327","version":"1","preferredName":"Grade","preferredDefinition":"Describes how closely a cancer resembles normal tissue of its same type, and the cancer's probable rate of growth","longName":"C18000","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic Grade","conceptCode":"C18000","definition":"The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05116195-EBA8-7341-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-09","modifiedBy":"ONEDATA","dateModified":"2005-11-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2222502","version":"1","preferredName":"UML DEFAULT CD","preferredDefinition":"Default Conceptual Domain for UML Loader","longName":"UML DEFAULT CD","context":"caCORE","contextVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5E53F3B-47A4-52D1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-04-29","modifiedBy":"DWARZEL","dateModified":"2021-04-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"204161A5-AE35-0A96-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-20","endDate":null,"createdBy":"UMLLOADER_CGOM","dateCreated":"2006-10-20","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"10559683","version":"1","preferredName":"Tumor Histology Type","preferredDefinition":"Something distinguishable as an identifiable class based on common qualities.","longName":"TUMOR_HIST_TYP","context":"NRG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"45","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Serous","valueDescription":null,"ValueMeaning":{"publicId":"3300681","version":"1","preferredName":"Serous","longName":"3300681","preferredDefinition":"Of or producing or containing serum.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Serous","conceptCode":"C14168","definition":"Of or producing or containing serum.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B126E752-C570-5EF2-E040-BB89AD43398A","latestVersionIndicator":"Yes","beginDate":"2011-11-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-11-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E2763C89-4551-66F9-E053-731AD00A305B","beginDate":"2022-07-06","endDate":null,"createdBy":"TSESU","dateCreated":"2022-07-06","modifiedBy":"TSESU","dateModified":"2022-07-06","deletedIndicator":"No"},{"value":"Clear Cell","valueDescription":null,"ValueMeaning":{"publicId":"3198849","version":"1","preferredName":"Clear Cell","longName":"3198849","preferredDefinition":"A cell with empty-appearing cytoplasm when viewed with a light microscope.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clear Cell","conceptCode":"C12478","definition":"A cell with empty-appearing cytoplasm when viewed with a light microscope.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D999C94-A5F9-E80A-E040-BB89AD4330DB","latestVersionIndicator":"Yes","beginDate":"2011-03-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E2763C89-4552-66F9-E053-731AD00A305B","beginDate":"2022-07-06","endDate":null,"createdBy":"TSESU","dateCreated":"2022-07-06","modifiedBy":"TSESU","dateModified":"2022-07-06","deletedIndicator":"No"},{"value":"Carcinosarcoma","valueDescription":null,"ValueMeaning":{"publicId":"5210574","version":"1","preferredName":"Carcinosarcoma (Malignant mullerian mixed tumor) (WHO code: 8950/3)","longName":"5210574","preferredDefinition":"A malignant tumor composed of a mixture of carcinomatous and sarcomatous elements.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Carcinosarcoma","conceptCode":"C34448","definition":"A malignant tumor composed of a mixture of carcinomatous and sarcomatous elements.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FB697C7-E5CD-4E5E-E050-BB89AD436E5D","latestVersionIndicator":"Yes","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E2763C89-4553-66F9-E053-731AD00A305B","beginDate":"2022-07-06","endDate":null,"createdBy":"TSESU","dateCreated":"2022-07-06","modifiedBy":"TSESU","dateModified":"2022-07-06","deletedIndicator":"No"},{"value":"Mixed Histology","valueDescription":null,"ValueMeaning":{"publicId":"4264925","version":"1","preferredName":"Mixed (normal and tumor) histology","longName":"4264925","preferredDefinition":"Mixed; being composed of a combination of normal and tumor cells.: The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mixed (Normal and Tumor)","conceptCode":"C26457","definition":"Mixed; being composed of a combination of normal and tumor cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Histology","conceptCode":"C16681","definition":"The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F67FEF75-A030-6988-E040-BB89AD432041","latestVersionIndicator":"Yes","beginDate":"2014-04-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E2763C89-4554-66F9-E053-731AD00A305B","beginDate":"2022-07-06","endDate":null,"createdBy":"TSESU","dateCreated":"2022-07-06","modifiedBy":"TSESU","dateModified":"2022-07-06","deletedIndicator":"No"},{"value":"High Grade Adenocarcinoma, NOS","valueDescription":null,"ValueMeaning":{"publicId":"10560001","version":"1","preferredName":"High Grade Endometrial Endometrioid Adenocarcinoma Not Otherwise Specified","longName":"10560001v1.00","preferredDefinition":"Endometrial endometrioid adenocarcinoma exhibiting more than 50% solid non-glandular, non-squamous growth._Not characterized in any other way.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Endometrial High Grade Endometrioid Adenocarcinoma","conceptCode":"C40148","definition":"Endometrial endometrioid adenocarcinoma exhibiting more than 50% solid non-glandular, non-squamous growth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2763C89-454D-66F9-E053-731AD00A305B","latestVersionIndicator":"Yes","beginDate":"2022-07-06","endDate":null,"createdBy":"TSESU","dateCreated":"2022-07-06","modifiedBy":"TSESU","dateModified":"2022-07-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E2763C89-4555-66F9-E053-731AD00A305B","beginDate":"2022-07-06","endDate":null,"createdBy":"TSESU","dateCreated":"2022-07-06","modifiedBy":"TSESU","dateModified":"2022-07-06","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E318AE6A-3D4A-66F7-E053-731AD00A35C4","latestVersionIndicator":"Yes","beginDate":"2022-07-06","endDate":null,"createdBy":"TSESU","dateCreated":"2022-07-06","modifiedBy":"TSESU","dateModified":"2022-07-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"Tumor Histology","url":null,"context":"NRG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E26FF5FD-9E4A-66FB-E053-731AD00AB816","latestVersionIndicator":"Yes","beginDate":"2022-07-06","endDate":null,"createdBy":"TSESU","dateCreated":"2022-07-06","modifiedBy":"TSESU","dateModified":"2022-07-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}